Analysis of continuous first-line treatment with docetaxel and carboplatin for advanced non-small cell lung cancer

The present study aimed to analyze the efficacy and safety of multiple cycles of docetaxel and carboplatin (CBDCA) as a first-line treatment in patients with advanced non-small cell lung cancer (NSCLC). Patients with stage III or IV NSCLC, whose treatment began between July 1999 and February 2003, w...

Descripción completa

Detalles Bibliográficos
Autores principales: AOKI, TAKUYA, EBIHARA, AKINORI, YOGO, YURIKA, SUEMASU, KEIICHI, SAKAMAKI, FUMIO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049720/
https://www.ncbi.nlm.nih.gov/pubmed/24932231
http://dx.doi.org/10.3892/ol.2014.1973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049720/
https://www.ncbi.nlm.nih.gov/pubmed/24932231
http://dx.doi.org/10.3892/ol.2014.1973

Ejemplares similares